DANVERS, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 25 presentations scheduled featuring Impella® heart pumps at the 67thAnnual Scientific Session of the American College of Cardiology (ACC), held March 10-12, 2018, at the Orange County Convention Center in Orlando, FL.
Impella heart pumps enable treatment and heart recovery for the growing high risk population of heart failure patients with advanced coronary artery disease. Abiomed has achieved multiple FDA PMA approvals, deeming Impella heart pumps safe and effective for Protected PCI for surgically turned-down complex patients, cardiogenic shock for emergency patients and for right heart failure with the Impella RP® heart pump. Abiomed is committed to advancing the science of heart recovery through technology, innovation, education and clinical research.
For more information about Abiomed and heart recovery, visit www.abiomed.com.
ABOUT IMPELLA HEART PUMPS
The Impella 2.5®, Impella CP®, Impella 5.0® and Impella LD® are FDA-approved heart pumps used to treat heart attack or cardiomyopathy patients in cardiogenic shock, and have the unique ability to enable native heart recovery, allowing patients to return home with their own heart. The Impella 2.5 and Impella CP devices are also approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI) such as stenting or balloon angioplasty, to re-open blocked coronary arteries. Abiomed's right-side heart pump, the Impella RP® device, is FDA approved to treat patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery.
To learn more about the Impella platform of heart pumps, including their approved indications and important safety and risk information associated with the use of the devices, please visit: www.protectedpci.com.
The ABIOMED logo, ABIOMED, Impella, Impella 2.5, Impella 5.0, Impella LD, Impella CP, Impella RP, and Recovering Hearts. Saving Lives. are registered trademarks of ABIOMED, Inc. in the U.S. and in certain foreign countries.
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com.
